16252-514
Generic: ciprofloxacin
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
Generic Name
ciprofloxacin
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
TABLET, FILM COATED
Active Ingredients
ciprofloxacin hydrochloride 250 mg/1
Identifiers & Regulatory
Product NDC
16252-514
Product ID
16252-514_1f76e627-ddbb-4c59-b9e6-7acb46c0954e
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Marketing Start
2004-06-09
Marketing End
2027-08-31
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
16252514
Hyphenated Format
16252-514
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ciprofloxacin (source: label)
Generic Name
ciprofloxacin (source: ndc)
Application Number
ANDA076794 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 250 mg/1
Packaging
- 24630 TABLET, FILM COATED in 1 BOX (16252-514-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "1f76e627-ddbb-4c59-b9e6-7acb46c0954e", "openfda": {}, "finished": false, "packaging": [{"description": "24630 TABLET, FILM COATED in 1 BOX (16252-514-00)", "package_ndc": "16252-514-00", "marketing_end_date": "31-AUG-27", "marketing_start_date": "09-JUN-04"}], "product_id": "16252-514_1f76e627-ddbb-4c59-b9e6-7acb46c0954e", "dosage_form": "TABLET, FILM COATED", "product_ndc": "16252-514", "generic_name": "Ciprofloxacin", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "CIPROFLOXACIN HYDROCHLORIDE", "strength": "250 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_end_date": "20270831", "marketing_start_date": "20040609"}